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3Duke University Medical Center, Durham, North CarolinaKarl G. Blume was born in Germany on April 10, 1937,
received his medical education under the mentorship of
Professor Georg W. Löhr at the University of Freiburg, and
graduated in 1963. After graduation, he undertook his resi-
dency atMarburg and then held 2 fellowships: one at Freiburg
and theotheratCityofHope, in1970and1971, respectively.His
earlyworkwas in red cell biochemistrydwork that hepursued
in his postdoctoral fellowship under Dr. Ernest Beutler.
In 1975, after discussions with Dr. E. Donnall Thomas in
Seattle and with his encouragement, Dr. Beutler wanted to
develop an allogeneic bone marrow transplantation (BMT)
program at the City of Hope. He recruited Karl to return to
City of Hope to establish the programda novel concept at
that time. The program at the City of Hope was, in many
ways, derived from work and discussions that Karl had with
colleagues at the Fred Hutchinson Cancer Research Center,
and resulted in lifelong friends from those early days in the
development of transplantation to treat diseases of bone
marrow and immune system origin. The ﬁrst transplantation
at City of Hope was performed on May 18, 1976.
Karl’s clinical and research work focused on the problems
that confront patients undergoing transplantation, namely
relapse prevention, immune reconstitution, graft-versus-
host disease and cytomegalovirus infection management
and, among his early insights, issues related to patients’
quality of life after transplantation and their long-term
health. In 1981, Karl was the principal investigator for the
City of Hope’s National Cancer Institute-approved program
project grant in transplantation, which contained projects
that focused on those problems, and he organized a talented
group of young laboratory and clinical scientists to work
together in understanding and solving these challenges.* Correspondence and reprint requests: Stephen J. Forman, MD, City of
Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010.
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http://dx.doi.org/10.1016/j.bbmt.2013.04.003Based on his success at City of Hope, Karl was recruited by
Stanley Schrier and Ron Levy in 1987 to begin a new trans-
plant program at Stanford University. Thus, he again devel-
oped from scratch his second successful transplantation
program, mentoring numerous young physicians, and
inspiring colleagues and staff to work with him in a common
quest to cure patients with hematologic malignancy and
return them to their normal lives. Just as he had done at City
of Hope, he developed and led another successful program
project grant application. He also established the Division of
Blood and Marrow Transplantation at Stanford, taking
a personal interest in the lives of each of his patients and
incorporating all aspects of the care team into their treat-
ment, including nursing, social work, dietary, physical
therapy, and conﬁrming again a model for patient care and
research in use at transplant programs around the country.
During that time, he trained both Rob Negrin and Nelson
Chao, who went on to direct transplantation programs at
Stanford and at Duke University, respectively. Therefore, Karl
was responsible for at least 3 of the major BMT programs in
the United States, not to mention the numerous fellows he
trained and mentored at City of Hope and Stanford.
In 2000, Karl attained emeritus status at Stanford and
stepped down from the role of chief of the BMT division to
develop the Stanford Cancer Institute. He continued to serve
Stanford University as associate director of research in the
Department of Medicine. In 2003, he directed his energies
toward developing and achieving the coveted National
Cancer Institute-designated cancer center status for the
Stanford Cancer Institute, a ﬁrst for the university.
Karl was also a driving force in 1994 in the founding of the
American Society of Blood andMarrow Transplantation, now
an international organization for physicians and researchers
committed to serving patients with a variety of blood dis-
eases. He was also a leader in the American Society of
Hematology and, for many years, was in charge of the
organization’s Career Development Program. Early on, he
recognized that our responsibilities were not only to our
patients now, but also to those who come to us in the future.
He became the ﬁrst honorary member of ASBMT, and, with
Richard O’Reilly, was the ﬁrst coeditor of the Biology of
Blood and Marrow Transplantation. Karl worked tirelessly to
make it the central journal in the ﬁeld, and when there were
questions about the cost of the ﬁrst issues, he made a
personal ﬁnancial donation to ensure the journal’s successful
launch.
Karl won many honors, both in the United States and
Germany, but his major legacy is the impact he had on the
thousands of patients he treated and the others he inspired
to follow in his footsteps. All of us who knew and loved him
knew that his highest priorities remained the quality of life
of his patients and their families, the well-being of hisTransplantation.
S.J. Forman et al. / Biol Blood Marrow Transplant 19 (2013) 845e846846transplantation team, and those of his colleagues around the
country and world. He held us all to high standards of
excellence, but he maintained it with wonderful warmth,
humor, and sensitivity over the decades and across the
continents. All of us who worked with him beneﬁted from
his respect and could always count on him to extend
a helping hand and open ears, as he wanted nothing more
than to help, to give of himself, and to be a force for good in
this world.
In addition to his interest in music, sportsdespecially
Stanford athleticsdand the politics of the world and its
impact on all of us, he was an exemplary family man. Hischildren, Philipp and Caroline, could always rely on him for
advice, affection, and guidance. In these last years, the lives
and activities of his grandchildren, Adrian, Katie, Laura,
Kevin, and David, were his focus and, of course, they adored
him. Vera, his wife of 45 years, was his partner in his life and
his work and, at difﬁcult times, always his source of strength
and calm.
For many of us in the ﬁeld who had the privilege of
knowing and working with him, and for the many patients
who are alive because of his work and dedication, the
sentiment of a Hebrew proverb seems appropriate: “Say not
in grief ‘he is no more,’ but live in thankfulness that he was.”
